Case | Age | Eye involved | Time from exposure to onset of ocular menifestations | Indications | Ocular history |
---|---|---|---|---|---|
1 [5] | 66 | unilateral | 2d | postmenopausal osteoporosis | no |
2 [6] | 75 | unilateral | 2d | osteoporosis | no |
3 [7] | 58 | unilateral | NA | osteoporosis | no |
4 [23] | 58 | unilateral | 10 h | osteoporosis | no |
5 [8] | 56 | unilateral | 12 h | postmenopausal osteoporosis | no |
6 [25] | 70 | unilateral | 1d | frontal hyperostosis after breast cancer | no |
7 [24] | 54 | bilateral | 1d | breast cancer with bone matastasis | no |
8 [9] | 78 | unilateral | 48 h | prostate cancer with bone matastasis | no |
9 [10] | 48 | unilateral | 24 h | breast cancer with bone matastasis | no |
10 [11] | 54 | unilateral | 3d | breast cancer with lung and bone matastasis | no |
11 [12] | 56 | bilateral | 72 h | prostate cancer treated with leuprolide | no |
12 [12] | 68 | bilateral | 60 h | prostate cancer treated with leuprolide | no |
13 [13] | 60 | unilateral | 24 h | osteoporosis and breast cancer | yes |
14 [14] | 62 | bilateral | 48 h | back and femur pain in MGUS | no |
15 [22] | 59 | unilateral | 2d | osteoporosis | no |
16a | 63 | bilateral | 24 h | postmenopausal osteoporosis | yes |